ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)

ImmuneOncia Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8,226	20,957	26,730	36,320	12,027
Short-Term Investments	3,100	5,000	-	6,000	8,708
Cash & Short-Term Investments	11,326	25,957	26,730	42,320	20,735
Cash Growth	-56.36%	-2.89%	-36.84%	104.10%	-23.41%
Accounts Receivable	421.83	11	633.65	-	-
Other Receivables	7,709	172.13	202.16	41.53	49.3
Receivables	8,131	183.13	835.81	41.53	49.3
Prepaid Expenses	297.34	376.95	520.18	232.62	98.18
Other Current Assets	107.93	118.97	884.02	72.89	38.05
Total Current Assets	19,863	26,636	28,970	42,667	20,920
Property, Plant & Equipment	494.54	892.1	547.33	997.96	835.55
Other Intangible Assets	4,908	5,429	5,987	6,503	7,064
Other Long-Term Assets	930.02	838.32	188.36	932.89	175.63
Total Assets	26,195	33,795	35,693	51,101	28,996
Accrued Expenses	137.63	103.34	154.4	128.24	214.87
Current Portion of Leases	51.05	50.11	98.69	216.39	76.78
Current Unearned Revenue	1,950	1,950	1,950	6,902	18.62
Other Current Liabilities	4,354	1,268	1,646	1,578	1,262
Total Current Liabilities	6,493	3,372	3,850	8,824	1,572
Long-Term Leases	44.01	86.83	24.27	98.24	24.47
Other Long-Term Liabilities	219.18	236.63	84,226	101,526	52,929
Total Liabilities	6,771	3,710	88,100	110,633	54,526
Common Stock	36,365	26,896	26,141	25,503	23,128
Additional Paid-In Capital	79,021	35,292	28,046	22,148	-
Retained Earnings	-110,721	-105,016	-113,921	-110,518	-50,045
Comprehensive Income & Other	14,759	8,637	7,326	3,336	1,387
Total Common Equity	19,424	-34,192	-52,407	-59,532	-25,530
Shareholders' Equity	19,424	30,086	-52,407	-59,532	-25,530
Total Liabilities & Equity	26,195	33,795	35,693	51,101	28,996
Total Debt	95.06	136.94	122.97	314.63	101.26
Net Cash (Debt)	11,231	25,820	26,607	42,005	20,633
Net Cash Growth	-56.50%	-2.96%	-36.66%	103.58%	-23.17%
Net Cash Per Share	199.46	492.28	510.53	904.13	4461.02
Filing Date Shares Outstanding	56.31	52.45	52.12	46.46	4.63
Total Common Shares Outstanding	56.31	52.45	52.12	46.46	4.63
Working Capital	13,370	23,264	25,120	33,842	19,348
Book Value Per Share	344.97	-651.90	-1005.59	-1281.39	-5519.70
Tangible Book Value	14,516	-39,621	-58,394	-66,035	-32,594
Tangible Book Value Per Share	257.81	-755.41	-1120.48	-1421.36	-7047.03
Machinery	1,514	1,443	1,173	1,148	1,053

Source: S&P Global Market Intelligence. Standard template. Financial Sources.